Current State and Challenges of Local Production of Vaccines in Nigeria
- PMID: 40496427
- PMCID: PMC12039692
- DOI: 10.1002/puh2.70006
Current State and Challenges of Local Production of Vaccines in Nigeria
Abstract
Background: Vaccination protects the population against infectious diseases and reduces their transmissibility. Potentials exist for local production of vaccines in Nigeria, as a means of addressing public health needs. However, challenges exist in certain critical aspects which limit development in this area. This study aimed at evaluating the challenges of local vaccines' manufacturing in Nigeria from the perspectives of relevant stakeholders.
Methods: This was a cross-sectional study. A structured questionnaire was used for data collection. The data obtained from the study were analysed descriptively.
Results: More than half of the study participants (55.5%) agreed that significant gaps exist with respect to access to vaccines in Nigeria. Only about one-quarter of the respondents (25.8%) were of the view that relevant legislative frameworks exist to support government funding in the area of vaccine production. One-third of the participants (32.3%) expressed confidence in the availability of trained human resources for vaccine production. Close to two-thirds of the respondents (61.7%) expressed dissatisfaction regarding the current funding for vaccine research and development, and a similar proportion (65.2%) were of the opinion that a lack of local manufacturing capacity contributed to the sub-optimal access to vaccines. Moreover, two-thirds (62.3%) disagreed that Nigeria was prepared for future pandemics.
Conclusion: Ill-suited policies, sub-optimal infrastructure, and inadequate research and development funding, are some factors which the study identified as contributory to the lack of access to vaccines in Nigeria. There is a need to improve incentives, infrastructural development and build human resource capacity for vaccine research and development to enhance local production in Nigeria.
Keywords: Africa; cold chain; healthcare; immunisation; infectious diseases; manufacturing; public health.
© 2024 The Author(s). Public Health Challenges published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Healthcare professionals' views on access to vaccines in Nigeria: A cross sectional study.Vaccine X. 2022 Oct 29;12:100235. doi: 10.1016/j.jvacx.2022.100235. eCollection 2022 Dec. Vaccine X. 2022. PMID: 36411828 Free PMC article.
-
Community pharmacy workforce willingness, readiness, and infrastructural capacity to deliver vaccination services: a cross-sectional survey in Nigeria.BMC Health Serv Res. 2025 Apr 2;25(1):485. doi: 10.1186/s12913-025-12655-3. BMC Health Serv Res. 2025. PMID: 40169982 Free PMC article.
-
Determinants of COVID-19 vaccination acceptance based on the novel Omale INDEPT FORCIS Framework and recommendations for subsequent pandemics: a qualitative study among community members in Ebonyi state, Nigeria.Int J Equity Health. 2024 Oct 28;23(1):223. doi: 10.1186/s12939-024-02284-3. Int J Equity Health. 2024. PMID: 39468612 Free PMC article.
-
Exploring future perspectives and pipeline progression in vaccine research and development.Ann Ig. 2024 Jul-Aug;36(4):446-461. doi: 10.7416/ai.2024.2614. Epub 2024 Mar 1. Ann Ig. 2024. PMID: 38436081 Review.
-
The need for Africa to develop capacity for vaccinology as a means of curbing antimicrobial resistance.Vaccine X. 2023 May 27;14:100320. doi: 10.1016/j.jvacx.2023.100320. eCollection 2023 Aug. Vaccine X. 2023. PMID: 37293248 Free PMC article. Review.
References
-
- United Nations Children's Fund (UNICEF) , Immunization, accessed May 28, 2023, https://www.unicef.org/immunization.
-
- World Health Organization (WHO) , Vaccines and Immunization, accessed May 28, 2023, https://www.who.int/health‐topics/vaccines‐and‐immunization.
LinkOut - more resources
Full Text Sources